Zacks Investment Research Lowers Acorda Therapeutics, Inc. (ACOR) to Strong Sell

Author

01 October, 2017

Therefore 28% are positive. Acorda Therapeutics had 24 analyst reports since August 25, 2015 according to SRatingsIntel. Pacific Crest maintained the shares of PCLN in report on Tuesday, November 8 with "Sector Weight" rating. Cowen & Co maintained Acorda Therapeutics Inc (NASDAQ:ACOR) on Tuesday, August 29 with "Buy" rating. Cantor Fitzgerald reaffirmed a "hold" rating and set a $18.00 price objective on shares of Acorda Therapeutics in a research note on Thursday. The firm earned "Outperform" rating on Thursday, September 3 by Macquarie Research. The firm has "Buy" rating given on Monday, March 13 by Janney Capital. Aegis Capital initiated the stock with "Buy" rating in Tuesday, September 1 report. The stock of Acorda Therapeutics Inc (NASDAQ:ACOR) earned "Market Perform" rating by Raymond James on Tuesday, September 1. The firm has "Overweight" rating by JP Morgan given on Wednesday, November 30.

Among 10 analysts covering Acorda Therapeutics (NASDAQ:ACOR), 4 have Buy rating, 0 Sell and 6 Hold. LVLT's profit will be $137.81 million for 35.16 P/E if the $0.38 EPS becomes a reality. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Acorda Therapeutics Inc (NASDAQ:ACOR). The stock increased 0.29% or $0.23 on September 28, reaching $80.51. Priceline Group Inc (NASDAQ:PCLN) has risen 44.63% since September 29, 2016 and is uptrending. It has outperformed by 25.96% the S&P500.

Investors sentiment increased to 1.54 in Q2 2017. Its down 0.10, from 1.09 in 2017Q1. It worsened, as 32 investors sold LVLT shares while 149 reduced holdings. 96 funds opened positions while 311 raised stakes. Municipal Employees Retirement System of MI lifted its position in shares of Acorda Therapeutics by 3.9% during the 2nd quarter. Guggenheim Ltd accumulated 0.01% or 104,183 shares. Moreover, North Star Investment Management Corp. has 0.01% invested in the company for 3,500 shares. (NYSE:LVLT) shares with value of $396,651 were sold by ALONSO HECTOR. (NYSE:CR) for 2,701 shares. Arizona State Retirement System holds 21,300 shares. (NYSE:LVLT) for 188,790 shares. The firm owned 179,045 shares of the biopharmaceutical company's stock after selling 84,740 shares during the quarter. Piedmont Investment Advisors LLC bought a new stake in shares of Acorda Therapeutics during the 2nd quarter valued at $199,000. New Mexico Educational Retirement Board, New Mexico-based fund reported 27,200 shares. 368,714 are held by Morgan Stanley. Bragg Fincl Advsr owns 1,285 shares for 0.38% of their portfolio. Ghost Tree Cap Ltd Limited Liability Company holds 1.64% or 400,000 shares in its portfolio. (NYSE:LVLT) or 292,825 shares. The company has market cap of $549.35 million. The Fluid Handling segment is a well-known provider of engineered fluid handling equipment, including Process Valves and Related Products, Commercial Valves and Other Products.

Since May 16, 2017, it had 0 buys, and 1 insider sale for $426,949 activity. (NYSE:CR) was sold by Baron Curtis A JR on Tuesday, May 16. (NYSE:LVLT) on Tuesday, December 13 with "Hold" rating. Therefore 43% are positive. BlackRock Kelso Capital had 7 analyst reports since August 3, 2015 according to SRatingsIntel. Seaport Global upgraded Crane Co. As per Tuesday, January 10, the company rating was initiated by Citigroup. Stifel Nicolaus maintained Crane Co. (NYSE:LVLT). Sandell Asset Mgmt holds 2.78% of its portfolio in Level 3 Communications, Inc. The rating was maintained by Jefferies on Wednesday, August 9 with "Buy". As per Tuesday, August 25, the company rating was maintained by JP Morgan. Stifel Nicolaus maintained the stock with "Buy" rating in Thursday, July 27 report. The firm has "Buy" rating given on Tuesday, August 29 by Stifel Nicolaus. Oppenheimer maintained the shares of CR in report on Monday, July 24 with "Buy" rating.

The stock decreased 0.43% or $0.1 on September 28, reaching $23.35. The correct version of this news story can be accessed at https://www.equitiesfocus.com/2017/09/30/prudential-financial-inc-reduces-stake-in-acorda-therapeutics-inc-acor.html. It has underperformed by 57.38% the S&P500.

Investors sentiment increased to 1.25 in 2017 Q2. Its up 0.07, from 1.18 in 2017Q1. Cambiar Investors Llc acquired 25,688 shares as Acorda Therapeutics Inc (ACOR)'s stock declined 39.72%. 21 funds opened positions while 64 raised stakes. Louisiana State Employees Retirement Systems owns 19,000 shares or 0.02% of their U.S. portfolio. Spark Invest Mngmt Ltd Company invested 0.53% of its portfolio in Acorda Therapeutics Inc (NASDAQ:ACOR).

Matt Sirovich increased its stake in Acorda Therapeutics Inc (ACOR) by 29.73% based on its latest 2017Q2 regulatory filing with the SEC.

First Foundation Advisors holds 0.44% of its portfolio in PCM Fund, Inc. for 672,541 shares. Scopia Capital Management Lp who had been investing in Acorda Therapeutics Inc for a number of months, seems to be bullish on the $1.09B market cap company. Walleye Trading Ltd Liability Corporation invested in 500 shares or 0% of the stock. The hedge fund run by Matt Sirovich held 7.22M shares of the health care company at the end of 2017Q2, valued at $142.31M, up from 5.57 million at the end of the previous reported quarter.

This company shares (CF) so far managed to recover 58.36% since collapsing to its 52-week low.

ACOR's mean recommendation on Reuter's scale presents no change from 2.5 thirty days ago to 2.5 now, which indicates a hold consensus from the analyst community. Public Employees Retirement System Of Ohio invested 0% of its portfolio in Acorda Therapeutics Inc (NASDAQ:ACOR).


More news